• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

与接受第二代抗抑郁药辅助治疗的双相I型障碍患者相比,双相II型障碍抑郁症患者的转换率更低。

Lower switch rate in depressed patients with bipolar II than bipolar I disorder treated adjunctively with second-generation antidepressants.

作者信息

Altshuler Lori L, Suppes Trisha, Black David O, Nolen Willem A, Leverich Gabriele, Keck Paul E, Frye Mark A, Kupka Ralph, McElroy Susan L, Grunze Heinz, Kitchen Christina M R, Post Robert

机构信息

Dept. of Psychiatry and Biobehavioral Sciences, University of California-Los Angeles, 300 UCLA Medical Plaza, Suite 1544, Box 957057, Los Angeles, CA 90095-7057.

出版信息

Am J Psychiatry. 2006 Feb;163(2):313-5. doi: 10.1176/appi.ajp.163.2.313.

DOI:10.1176/appi.ajp.163.2.313
PMID:16449487
Abstract

OBJECTIVES

The authors compared the switch rate into hypomania/mania in depressed patients treated with second-generation antidepressants who had either bipolar I or bipolar II disorder.

METHOD

In a 10-week trial, 184 outpatients with bipolar depression (134 with bipolar I disorder, 48 with bipolar II disorder, two with bipolar disorder not otherwise specified) were treated with one of three antidepressants as an adjunct to mood stabilizers. The patients' switch rates were assessed. Switch was defined as a Young Mania Rating Scale (YMRS) score >13 or a Clinical Global Impression (CGI) mania score > or =3 (mildly ill).

RESULTS

Depressed subjects with bipolar II disorder had a significantly lower acute switch rate into hypomania/mania when either YMRS or CGI criteria were used to define switch.

CONCLUSIONS

These data suggest that depressed patients with bipolar II disorder are less vulnerable than those with bipolar I disorder to switch into hypomania/mania when treated with an antidepressant adjunctive to a mood stabilizer.

摘要

目的

作者比较了患有双相I型或双相II型障碍的抑郁症患者在接受第二代抗抑郁药治疗时转为轻躁狂/躁狂的发生率。

方法

在一项为期10周的试验中,184例双相抑郁症门诊患者(134例双相I型障碍,48例双相II型障碍,2例未另行指定的双相障碍)接受三种抗抑郁药之一作为心境稳定剂的辅助治疗。评估患者的转换率。转换定义为杨氏躁狂评定量表(YMRS)评分>13或临床总体印象(CGI)躁狂评分>或=3(轻度疾病)。

结果

当使用YMRS或CGI标准定义转换时,双相II型障碍的抑郁症患者转为轻躁狂/躁狂的急性转换率显著较低。

结论

这些数据表明,在使用心境稳定剂辅助抗抑郁药治疗时,双相II型障碍的抑郁症患者比双相I型障碍的患者更不容易转为轻躁狂/躁狂。

相似文献

1
Lower switch rate in depressed patients with bipolar II than bipolar I disorder treated adjunctively with second-generation antidepressants.与接受第二代抗抑郁药辅助治疗的双相I型障碍患者相比,双相II型障碍抑郁症患者的转换率更低。
Am J Psychiatry. 2006 Feb;163(2):313-5. doi: 10.1176/appi.ajp.163.2.313.
2
Lower Switch Rate in Depressed Patients With Bipolar II Than Bipolar I Disorder Treated Adjunctively With Second-Generation Antidepressants.与使用第二代抗抑郁药辅助治疗的双相I型障碍患者相比,双相II型障碍抑郁症患者的转换率更低。
Focus (Am Psychiatr Publ). 2023 Oct;21(4):430-433. doi: 10.1176/appi.focus.23021020. Epub 2023 Oct 15.
3
Risk of switch in mood polarity to hypomania or mania in patients with bipolar depression during acute and continuation trials of venlafaxine, sertraline, and bupropion as adjuncts to mood stabilizers.在文拉法辛、舍曲林和安非他酮作为心境稳定剂辅助药物用于双相抑郁患者的急性和延续性试验期间,心境极性转换为轻躁狂或躁狂的风险。
Am J Psychiatry. 2006 Feb;163(2):232-9. doi: 10.1176/appi.ajp.163.2.232.
4
Predictors of switching from mania to depression in a large observational study across Europe (EMBLEM).一项横跨欧洲的大型观察性研究(EMBLEM)中从躁狂发作转为抑郁发作的预测因素
J Affect Disord. 2009 Nov;118(1-3):118-23. doi: 10.1016/j.jad.2009.02.007. Epub 2009 Mar 9.
5
Antidepressant-induced mania in bipolar patients: identification of risk factors.双相情感障碍患者中抗抑郁药诱发的躁狂:危险因素的识别
J Clin Psychiatry. 2001 Apr;62(4):249-55. doi: 10.4088/jcp.v62n0406.
6
Placebo-controlled study of quetiapine monotherapy in ambulatory bipolar spectrum disorder with moderate-to-severe hypomania or mild mania.安慰剂对照研究喹硫平单药治疗伴有中重度轻躁狂或轻度躁狂的门诊双相情感障碍。
J Affect Disord. 2010 Jul;124(1-2):157-63. doi: 10.1016/j.jad.2009.11.014. Epub 2009 Dec 5.
7
Correlates of treatment-emergent mania associated with antidepressant treatment in bipolar depression.双相抑郁中与抗抑郁药治疗相关的治疗引发躁狂的相关因素。
Am J Psychiatry. 2009 Feb;166(2):164-72. doi: 10.1176/appi.ajp.2008.08030322. Epub 2008 Nov 17.
8
A randomized trial comparing paroxetine and venlafaxine in the treatment of bipolar depressed patients taking mood stabilizers.一项比较帕罗西汀和文拉法辛对服用心境稳定剂的双相抑郁患者治疗效果的随机试验。
J Clin Psychiatry. 2002 Jun;63(6):508-12. doi: 10.4088/jcp.v63n0607.
9
Mania in the Nordic countries: patients and treatment in the acute phase of the EMBLEM study.北欧国家的躁狂症:EMBLEM研究急性期的患者与治疗
Nord J Psychiatry. 2009;63(4):285-91. doi: 10.1080/08039480802663890.
10
Rates of remission/euthymia with quetiapine in combination with lithium/divalproex for the treatment of acute mania.喹硫平联合锂盐/丙戊酸盐治疗急性躁狂症的缓解/心境正常率。
J Affect Disord. 2007;100 Suppl 1:S55-63. doi: 10.1016/j.jad.2007.02.008. Epub 2007 Mar 26.

引用本文的文献

1
Assessment and Management of Bipolar Disorder.双相情感障碍的评估与管理。
Focus (Am Psychiatr Publ). 2023 Oct;21(4):399-400. doi: 10.1176/appi.focus.23021017. Epub 2023 Oct 15.
2
Bipolar II Disorder: Understudied and Underdiagnosed.双相II型障碍:研究不足且诊断不足。
Focus (Am Psychiatr Publ). 2023 Oct;21(4):354-362. doi: 10.1176/appi.focus.20230015. Epub 2023 Oct 15.
3
Pharmacogenomic overlap between antidepressant treatment response in major depression & antidepressant associated treatment emergent mania in bipolar disorder.
抗抑郁治疗反应在重度抑郁症和双相情感障碍中抗抑郁药相关治疗出现躁狂症之间的药物基因组重叠。
Transl Psychiatry. 2024 Feb 13;14(1):93. doi: 10.1038/s41398-024-02798-y.
4
The clinical characterization of the adult patient with bipolar disorder aimed at personalization of management.成年双相情感障碍患者的临床特征,旨在实现管理的个性化。
World Psychiatry. 2022 Oct;21(3):364-387. doi: 10.1002/wps.20997.
5
Short Term Second-Generation Antidepressant Monotherapy in Acute Depressive Episodes of Bipolar II Disorder: A Systematic Review and Meta-Analysis.双相 II 障碍急性抑郁发作中短期第二代抗抑郁药单药治疗:系统评价和荟萃分析。
Psychopharmacol Bull. 2022 May 31;52(2):45-72.
6
Comparative Efficacy and Tolerability of Adjunctive Pharmacotherapies for Acute Bipolar Depression: A Systematic Review and Network Meta-analysis.辅助治疗急性双相抑郁的疗效和耐受性比较:系统评价和网络荟萃分析。
Can J Psychiatry. 2021 Mar;66(3):274-288. doi: 10.1177/0706743720970857. Epub 2020 Nov 11.
7
Evidence-Based Principles for Bipolar Disorder Treatment.双相情感障碍治疗的循证原则
Focus (Am Psychiatr Publ). 2019 Jul;17(3):272-274. doi: 10.1176/appi.focus.17303. Epub 2019 Jul 16.
8
Personalized Pharmacotherapy for Bipolar Disorder: How to Tailor Findings From Randomized Trials to Individual Patient-Level Outcomes.双相情感障碍的个性化药物治疗:如何将随机试验结果应用于个体患者层面的结局。
Focus (Am Psychiatr Publ). 2019 Jul;17(3):206-217. doi: 10.1176/appi.focus.20190005. Epub 2019 Jul 16.
9
Changes in inflammation with treatment for bipolar II depression: Pilot trial data on differential effects of psychotherapy and medication.双相II型抑郁症治疗中的炎症变化:心理治疗和药物治疗差异效应的初步试验数据
Neurol Psychiatry Brain Res. 2019 Sep;33:112-118. doi: 10.1016/j.npbr.2019.07.007. Epub 2019 Aug 10.
10
Bipolar II Disorder: Not So Sure It Is Time for Something New.双相II型障碍:不确定现在是否是推出新事物的时候。
Can J Psychiatry. 2019 Aug;64(8):544-547. doi: 10.1177/0706743719852097. Epub 2019 May 19.